The content on this site is intended for healthcare professionals only
Prophylactic gastrectomy in CDH1 mutation
Published: 22 Jul 2020
Views: 1007
Prof. Franco Roviello - University of Siena, Italy
Prof. Franco Roviello from the University of Siena, Italy, speaks at the Hereditary Breast and Gastric Cancers conference about prophylactic gastrectomy in CDH1 mutation.
Related Videos
Tumour agnostic treatments in GI cancer
Dr Nicola Normanno and Dr Katja Schmitz
1 Feb 2022
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and con...
Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain
8 Jun 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
Updates on criteria for patient selection and surgical management in advanced ov...
Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA
20 Jan 2021
PARP inhibitors in prostate cancer: A promise delivered
Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA
1 Dec 2020
PARP inhibitors for prostate cancer - Nurse's view
Laurie M. Connors - Vanderbilt University School of Nursing, Nashville, USA
24 Nov 2020
Critical issues in drug and biomarker development
Prof Tracy Lively - National Cancer Institute, USA
2 Nov 2020
Epidemiology of gastric cancer
Prof. Carlo La Vecchia - University of Milan, Italy
22 Jul 2020
Future perspective of CDH1 mutation in gastric and breast cancers
Dr. Giovanni Corso - University of Milan, Italy, Meeting president
22 Jul 2020